Barostim neo™ is the second-generation implantable device, from CVRx. In August 2011 they announced the launch of a clinical trial to evaluate Barostim therapy for the treatment of heart failure. The Barostim neo features a unilateral, 1mm electrode and a new smaller, more advanced generator to allow for more focused and efficient delivery of therapy, leading to shorter procedure ti ...
Read More...
This site complies with the HONcode standard for trustworthy health
information:
verify here.
About - Terms of use - Privacy Policy
Upgrade Your Body (TM) is a project run by Consolidated Computing Pty Ltd.